This statistic illustrates the expenditure of AbbVie on research and development as a percentage of revenue from 2012 to 2023. In 2023, AbbVie spent some 14 percent of its revenue on research and development, which is a low percentage for a leading pharmaceutical company. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals. On May 8, 2020, AbbVie completed the acquisition of Allergan plc.
AbbVie's research and development spending as a share of revenue from 2012 to 2023
(in million U.S. dollars)
This statistic was assembled from several of Abbvie's annual reports.
* Research and development expenses in 2018 increased from 2017 principally due to a $5.1 billion intangible asset impairment charge related to
IPR&D acquired as part of the 2016 Stemcentrx acquisition following the decision to stop enrollment in the TAHOE trial.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
AbbVie. (February 20, 2024). AbbVie's research and development spending as a share of revenue from 2012 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 19, 2024, from https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie. "AbbVie's research and development spending as a share of revenue from 2012 to 2023 (in million U.S. dollars)." Chart. February 20, 2024. Statista. Accessed November 19, 2024. https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie. (2024). AbbVie's research and development spending as a share of revenue from 2012 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 19, 2024. https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie. "Abbvie's Research and Development Spending as a Share of Revenue from 2012 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 20 Feb 2024, https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie, AbbVie's research and development spending as a share of revenue from 2012 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/ (last visited November 19, 2024)
AbbVie's research and development spending as a share of revenue from 2012 to 2023 (in million U.S. dollars) [Graph], AbbVie, February 20, 2024. [Online]. Available: https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
